Soleno Therapeutics, Inc. (SLNO)
May 18, 2026 - SLNO was delisted (reason: acquired by NBIX)
53.01
0.00 (0.00%)
Inactive · Last trade price on May 15, 2026
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Soleno Therapeutics stock had an average target of $53.
Price Target: $53 (-0.02%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Soleno Therapeutics stock from 7 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
476.88M
from 190.41M
Increased by 150.46%
Revenue Next Year
717.10M
from 476.88M
Increased by 50.37%
EPS This Year
4.03
from 0.39
Increased by 932.64%
EPS Next Year
6.41
from 4.03
Increased by 59.18%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 544.7M | 866.3M | |
| Avg | 476.9M | 717.1M | |
| Low | 425.0M | 528.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 186.1% | 81.6% | |
| Avg | 150.5% | 50.4% | |
| Low | 123.2% | 10.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.83 | 10.42 | |
| Avg | 4.03 | 6.41 | |
| Low | 2.64 | 3.54 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,394.2% | 158.6% | |
| Avg | 932.6% | 59.2% | |
| Low | 575.9% | -12.2% |